Immunomodulatory drugs (IMiDs), including thalidomide derivatives such as lenalidomide and pomalidomide, offer therapeutic benefit in several hematopoietic malignancies and autoimmune/inflammatory diseases. However, it is difficult to study the IMiD mechanism of action in murine disease models because murine cereblon (CRBN), the substrate receptor for IMiD action, is resistant to some... (Source: Proceedings of the National Academy of Sciences)
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2QC0qMg
Τρίτη 13 Νοεμβρίου 2018
Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs [Immunology and Inflammation]
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.